行业盛典 再启新程|第七届中国医药创新与投资大会初版日程发布

HE Ruyi

Chairman of PhIRDA International Regulatory Science Specialty Committee, CMO of RemeGen, CMO of SDIC, Former Chief Scientist of CDE

Dr. Ruyi He was the Chief Scientist at the Center for Drug Evaluation at the Chinese Food and Drug Administration (CFDA). Dr. He joined CFDA in July 2016, after having worked at the US Food and Drug Administration (FDA) for more than 17 years. He participated CFDA drug review and evaluation system reform in the recent years.Dr. Ruyi He joined the US Center for Drug Evaluation and Research (CDER) at the US FDA in 1999 as a Medical Officer in the office of New Drug. He was the Acting Deputy Director in the division of GI and Inborn error Drug Products. He chaired several working groups that were tasked with drafting and finalizing guidelines for industry. Dr. Ruyi He has received many awards since he joined the FDA.Dr. Ruyi He received his medical degree from China Medical University. He completed his intern and residency training in Internal Medicine at Howard University Hospital in Washington, DC. He received his clinical and research training at the National Institutes of Health (NIH) in Bethesda, Maryland. He is a licensed, board-certified physician in several States in the America.